MedTrace Logo

Effects of Cosopt on IOP and on Ocular Diastolic Perfusion Pressure

NCT00796198 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2008-11-25

No results posted yet for this study

Summary

Hypothesis: Studies suggest that patients with low diastolic velocity and high resistivity index in the ophthalmic artery had more progressive visual fields, the investigators hypothesize therefore that addition of Cosopt to Latanoprost could improve ocular diastolic perfusion pressure (ODPP).

Objective: To evaluate the effects of Cosopt on ODPP in patients not adequately controlled with latanoprost alone.

Conditions

Interventions

DRUG

Xalatan+Cosopt

Xalatan ophthalmic solution one drop at 10pm + Cosopt ophthalmic solution one drop at 8am and one drop at 8 pm

DRUG

Xalatan

Xalatan ophthalmic solution one drop at 10pm

Sponsors & Collaborators

  • University of Turin, Italy

    lead OTHER

Principal Investigators

  • Teresa Rolle, MD, Assistent Professor · University of Turin, Department of Clinical Physiopathology, Section of Ophthalmology, Eye Clinic

  • Teresa Rolle, MD, Assistent Professor · University of Turin, Department of Clinical Physiopathology-Section of Ophthalmology-Eye Clinic

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2009-06-30
Completion
2009-07-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00796198 on ClinicalTrials.gov